EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • February 12th, 2018 • Boston Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Executive Retention Agreement (the “Agreement”) is made and entered into as of January 1, 2018 (the “Effective Date”) by and between BOSTON THERAPEUTICS, INC., a Delaware corporation (the “Company”), and LORAINE UPHAM (the “Executive”).
CONTRIBUTION AGREEMENT Dated as of January 1, 2018 by and among Boston Therapeutics, Inc., a Delaware corporation and CureDM Group Holdings, LLC, a Delaware limited liability company and the Members of CureDM Group Holdings, LLC CONTRIBUTION AGREEMENTContribution Agreement • February 12th, 2018 • Boston Therapeutics, Inc. • Pharmaceutical preparations • New York
This Contribution Agreement (“Agreement”), dated as of 12:00 a.m. January 1, 2018 (the “Closing Date”), is by and among Boston Therapeutics, Inc. (“BTHE”), a corporation organized under the laws of the State of Delaware, having an office for the transaction of business at 354 Merrimack Street, #4, Lawrence, Massachusetts 01843 and CureDM Group Holdings, LLC (“CureDM”), a limited liability company organized under the laws of the State of Delaware, having an office for the transaction of business at 5901 Indian School Road, Albuquerque, New Mexico 87110, and the members of CureDM as listed on the signature pages and Schedule A hereto, constituting all of the members of CureDM (collectively, the “CureDM Members”, and each individually, a “CureDM Member”), each having an address as set forth on the signature pages hereto.
